Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists

Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

(2015) Michael P. Curry et al.   GASTROENTEROLOGY

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

(2015) Michael Charlton et al.   GASTROENTEROLOGY

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

(2015) K. Rajender Reddy et al.   HEPATOLOGY

Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1

(2015) Mark S. Sulkowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

(2015) Marc Bourlière et al.   LANCET INFECTIOUS DISEASES

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

(2015) Susanna Naggie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010

(2014) Maxine M. Denniston et al.   ANNALS OF INTERNAL MEDICINE

ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection

(2014) Pietro Andreone et al.   GASTROENTEROLOGY

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

(2014) Eric Lawitz et al.   LANCET

An Interferon-free Antiviral Regimen for HCV after Liver Transplantation

(2014) Paul Y. Kwo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

(2014) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

(2014) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

(2014) Kris V. Kowdley et al.   NEW ENGLAND JOURNAL OF MEDICINE

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

(2014) Peter Ferenci et al.   NEW ENGLAND JOURNAL OF MEDICINE

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

(2014) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Provision of Clinical Pharmacist Services for Individuals With Chronic Hepatitis C Viral Infection

(2014) Rima A. Mohammad et al.   PHARMACOTHERAPY

Hepatitis C Infection Is Very Rarely Treated among Hemodialysis Patients

(2013) David A. Goodkin et al.   AMERICAN JOURNAL OF NEPHROLOGY

Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation

(2013) Johanna Knapstein et al.   DIGESTIVE AND LIVER DISEASE

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource

(2013) Donald B. Smith et al.   HEPATOLOGY

A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to care

(2013) Christopher E. McGowan et al.   HEPATOLOGY

Hepatitis C in the United States

(2013) Scott D. Holmberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatitis C Testing, Infection, and Linkage to Care Among Racial and Ethnic Minorities in the United States, 2009–2010

(2012) Rania A. Tohme et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Global Burden of Hepatitis C: Considerations for Healthcare Providers in the United States

(2012) Francisco M. Averhoff et al.   CLINICAL INFECTIOUS DISEASES

A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation

(2012) Gregory T. Everson et al.   HEPATOLOGY

Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: Is it feasible?

(2012) Jérôme Dumortier et al.   JOURNAL OF CLINICAL VIROLOGY

Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review

(2012) Sean Yaphe et al.   SEXUALLY TRANSMITTED INFECTIONS

Hepatitis C virus infection in USA: an estimate of true prevalence

(2011) Eric Chak et al.   LIVER INTERNATIONAL

Therapeutics: New drugs hit the target

(2011) Jana Schlütter   NATURE

Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers

(2011) Sanjeev Arora et al.   NEW ENGLAND JOURNAL OF MEDICINE

Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States☆☆☆

(2010) David B. Rein et al.   DIGESTIVE AND LIVER DISEASE

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis

(2010) Zhong-Hua Lin et al.   HEPATOLOGY

The natural history of recurrent hepatitis C and what influences this

(2010) Edward J. Gane   LIVER TRANSPLANTATION

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

(2009) Gary L. Davis et al.   GASTROENTEROLOGY